GlycoMimetics Inc (NASDAQ:GLYC) does about 4.36M shares in volume on a normal day but saw 1112985 shares change hands in Tuesday trading. The company now has a market cap of 17.33M USD. Its current market price is $0.27, marking a decrease of -9.22% compared to the previous close of $0.30. The 52 week high reached by this stock is $3.53 whilst the lowest price level in 52 weeks is $0.23.
GlycoMimetics Inc (GLYC) has a 20-day trading average at $0.2724 and the current price is -92.39% off the 52-week high compared with 14.38% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5682 and its 200-day simple moving average is $1.8095. If we look at the stock’s price movements over the week, volatility stands at 11.93%, which decreases to 10.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.67 to suggest the stock is neutral.
The consensus objective for the share price is $0.75, suggesting that the stock has a potential upside of 64.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 22, 2023 when CapitalOne initiated the stock to “Overweight” and issued a price target of $12. Jefferies upgraded the stock to “Buy” from Hold on November 12, 2021 at a price target of $3-$4. ROTH Capital initiated its price target at $12.
GlycoMimetics Inc (GLYC) stock is down -19.52% over the week and -0.81% over the past month. Its price is -88.61% year-to-date and -84.55% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.13 above consensus estimates by 0.05. The company’s next earnings report forecasts estimating quarterly EPS at -0.17 and -0.62 for whole year.
To reach the target analysts have set, the stock logically needs to grow 64.0 percent from here.
The company has a return on investment of -128.94% and return on equity of -81.84%. The beta has a value of 2.18. Price to book ratio is 0.60 and price to sales ratio is 1732.68.
